On Sep. 2, 2015, CFDA released the draft of “Administrative Measures for Registration of Foods for Special Medical Purpose”, which will be open for public consultation until Oct. 1, 2015.
Under the new regulatory environment, foods for special medical purposes (FSMPs) will be required to be registered with CFDA prior to sale in Chinese market.
Applicable scope:
This regulation is applicable to both FSMPs for infants (0-12 months) and FSMPs for the population above 1 year old, and is also applicable to both domestically produced and imported FSMPs.
Competent authority:
CFDA will take charge of the registration of FSMPs, and will organize relevant experts to review the product registration.
Application dossiers for FSMPs registration:
Application form for FSMPs registration
Product R&D report and product formula and relevant evidences
Production process
Product quality standards and requirements
Product label and users’ directions
Sample test report
Materials proving the capabilities of R&D, production and inspection
Other materials proving the product safety and nutrient sufficiency
Clinic test report is required for the registration of nutritionally complete foods with a specific formulation
FSMPs re-registration:
The validity period of an FSMP registration certificate will be five years. The application for re-registration should be made 60 days before the expiry of the certificate by submitting the following dossiers:
Application form for re-registration of FSMPs
FSMPs registration certificate
Detailed information regarding product manufacturing, sale and sampling inspection during the 5 years, as well as the statements for the unqualified products
Conclusions of product use condition and adverse reactions within the 5 years
Labeling requirements:
There should not be any claims relating to disease prevention and/or indications of curative functions.
There should be obvious indications of “use under the guidance of doctors or clinical dieticians”, “this product is unsuitable for non-target consumer groups”, and “this product is prohibited for parenteral nutritional support and intravenous injection”.